Fig. 3From: The effects of a prolonged exposure workshop with and without consultation on provider and patient outcomes: a randomized implementation trialCAPS-5 for Patients at Their Second (Final) Assessment. Note: CAPS-5, Clinician Administered PTSD Scale for DSM-5. The session at which the second assessment occurred varied from session 3-15. This graph illustrates the treatment condition differences at 4 of those assessment pointsBack to article page